Pharma Mar (XMAD:PHM) COGS-to-Revenue : 0.05 (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar COGS-to-Revenue?

Pharma Mar's Cost of Goods Sold for the three months ended in Mar. 2024 was €1.8 Mil. Its Revenue for the three months ended in Mar. 2024 was €38.0 Mil.

Pharma Mar's COGS to Revenue for the three months ended in Mar. 2024 was 0.05.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Pharma Mar's Gross Margin % for the three months ended in Mar. 2024 was 95.35%.

Pharma Mar COGS-to-Revenue Historical Data

The historical data trend for Pharma Mar's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar COGS-to-Revenue Chart

Pharma Mar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.06

0.05

0.07

0.06

Pharma Mar Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.06	0.04	0.08	0.06	0.05

Pharma Mar COGS-to-Revenue Calculation

Pharma Mar's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	9.613	/	158.153
	=	0.06

Pharma Mar's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.765	/	37.966
	=	0.05

Pharma Mar (XMAD:PHM) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Pharma Mar's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1.765 / 37.966
	=	95.35 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Pharma Mar COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharma Mar's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar (XMAD:PHM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

PHMMF:USA PHMe:UK 0RC6:UK

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.